当中国创新药迎来黄金期

药智网
16 Jun

在全球医药产业变革的浪潮中,BD交易正成为中国创新药企业破局突围的关键引擎。2025年,创新药领域的BD交易呈现出爆发式增长态势,一场关于技术、资本与市场的深度博弈正在上演,而中国创新药企正以亮眼的表现站在这场变革的潮头。数据背后的热度风暴据不完全统计,仅2025年5月,就至少有6家国内创新药企对外官宣了BD交易订单,且大部分为中外药企之间的跨境合作。这种高频次的交易并非偶然,而是2025年创新药...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10